NCT01388699|Completed
Loading search results
Sponsor study identifier
observational
60
1 country
1
Study Start
October 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2011
Actual (reported)Study Completion
December 2011
Actual (reported)Recently, there is evidence that endothelial activation and dysfunction are associated with migraine, especially in female migraineurs with aura. Our objectives were to determine whether novel endothelial function markers are altered in female migraineurs with aura compared to age-matched controls.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2010
Date type not reportedThis date has not been verified as actual or estimated.
July 5, 2011
Actual (reported)July 7, 2011
Actual (reported)August 2011
Actual (reported)December 2011
Actual (reported)Endothelial Microparticles
Levels of endothelial microparticlel in the peripheral blood using flow cytometry
baseline
Levels of circulating Endothelial Progenitor Cells
baseline
Digital pulse volume change
baseline
female migraineurs with aura
healthy women without headache syndrome
female migraineurs from outpatient clinic
Center for Stroke Research Berlin
Berlin, 10117, Germany
Liman TG, Neeb L, Rosinski J, Wellwood I, Reuter U, Doehner W, Heuschmann PU, Endres M. Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study. Cephalalgia. 2012 Apr;32(6):459-66. doi: 10.1177/0333102412444014. Epub 2012 Apr 20.
Liman TG, Bachelier-Walenta K, Neeb L, Rosinski J, Reuter U, Bohm M, Endres M. Circulating endothelial microparticles in female migraineurs with aura. Cephalalgia. 2015 Feb;35(2):88-94. doi: 10.1177/0333102414529671. Epub 2014 Apr 8.
Thomas Liman, MD
Center for Stroke Research Berlin, Charité Campus Mitte
First Submitted
July 5, 2011
First Posted
July 7, 2011
Study Start
October 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2011
Actual (reported)Study of NXN 188 for the Treatment of Migraine With Aura
Contact the study team to confirm eligibility.
Liman TG, Neeb L, Rosinski J, Reuter U, Endres M. Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura. Headache. 2016 Sep;56(8):1274-9. doi: 10.1111/head.12839. Epub 2016 May 30.
Study Completion
December 2011
Actual (reported)Last Updated
July 18, 2018
Record last verified: 2018-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: